Immediate Impact
1 from Science/Nature 64 standout
Citing Papers
Cancer therapy with antibodies
2024 Standout
The therapeutic age of the neonatal Fc receptor
2023 Standout
Works of László Rejtő being referenced
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| László Rejtő | 136 | 105 | 43 | 62 | 32 | 358 | |
| Dawn Swan | 176 | 74 | 39 | 78 | 42 | 346 | |
| Robert M. Fox | 153 | 40 | 79 | 82 | 24 | 341 | |
| Stephen I. Bulova | 141 | 97 | 48 | 123 | 21 | 399 | |
| Ahmad Iftikhar | 82 | 128 | 27 | 91 | 31 | 372 | |
| Atsushi Kisanuki | 93 | 88 | 39 | 32 | 28 | 383 | |
| Ilenia Di Cola | 105 | 77 | 17 | 35 | 24 | 357 | |
| K Rhyner | 152 | 101 | 97 | 60 | 47 | 368 | |
| Yasuo Matsuoka | 60 | 83 | 43 | 27 | 48 | 395 | |
| D. H. Cowan | 186 | 101 | 61 | 119 | 32 | 412 | |
| Abdullah Hacıhanefioğlu | 212 | 121 | 50 | 86 | 30 | 408 |
All Works
Loading papers...